These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 17436860
1. [Susceptibility of clinical isolates from primary care clinics to oral antibacterial agents]. Fujimura T, Yoshida I, Yamano Y. Jpn J Antibiot; 2007 Feb; 60(1):17-30. PubMed ID: 17436860 [Abstract] [Full Text] [Related]
2. [Antibacterial activity of oral Cephems against various clinically isolated strains]. Oshiro T, Fukutomi Y, Takayanagi M, Kusaba K, Nagasawa Z, Aoki Y, Nagayama A. Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876 [Abstract] [Full Text] [Related]
3. [Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory]. Nakamura T, Takahashi H. Jpn J Antibiot; 2004 Dec; 57(6):465-74. PubMed ID: 15747584 [Abstract] [Full Text] [Related]
4. [Antibacterial activity of quinolones against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory]. Nakamura T, Shimizu C, Hirakawa K, Inui S, Okuda K, Nakata C, Fujimoto H, Okura H, Uemura Y, Takahashi H. Jpn J Antibiot; 2009 Jun; 62(3):194-202. PubMed ID: 19882980 [Abstract] [Full Text] [Related]
5. [In vitro activity of sitafloxacin against clinical isolates in 2009]. Amano A, Matsuzaki K, Kishi N, Saika T, Hasegawa M, Ikeda F, Matsumoto T, Yamaguchi H, Kanda Y, Shiozawa T. Jpn J Antibiot; 2010 Dec; 63(6):411-30. PubMed ID: 21425595 [Abstract] [Full Text] [Related]
6. [In vitro antibacterial activities of cefteram and other beta-lactam agents against recent clinical isolates]. Yamaguchi K, Ohno A, Takahashi S, Hayashi M, Yamanaka K, Hirakata Y, Mitsuyama J. Jpn J Antibiot; 1998 Jan; 51(1):11-25. PubMed ID: 9557273 [Abstract] [Full Text] [Related]
7. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria]. Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T. Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380 [Abstract] [Full Text] [Related]
8. [In vitro activity of sitafloxacin against clinical isolates in 2012]. Amano A, Matsuzaki K, Kishi N, Koyama H, Hasegawa M, Ikeda F, Matsumoto T, Yamaguchi H, Okutani Y. Jpn J Antibiot; 2013 Dec; 66(6):311-30. PubMed ID: 24649797 [Abstract] [Full Text] [Related]
9. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents --special references to bacteria isolated between April 2008 and March 2009]. Shinagawa N, Hasegawa M, Hirata K, Furuhata T, Mizukuchi T, Osanai H, Yanai Y, Hata F, Sasaki K, Someya T, Harada K, Oono K, Tokita S, Nakamura M, Shibuya H, Hasegawa I, Kimura M, Oshima H, Maeda H, Mukaiya M, Kihara C, Kosho W, Hoshikawa T, Kimura H, Ushijima Y, Yae-Hoon Y, Aikawa N, Abe S, Yura J, Takeyama H, Wakasugi T, Taniguchi M, Mizuno I, Fukui T, Mashita K, Ishikawa S, Mizuno A, Moori N, Sumita N, Kubo S, Lee S, Oomura T, Kobayashi Y, Tsuji T, Yamaue H, Kawai M, Takesue Y, Tanaka N, Kimura H, Iwagaki H, Sueda T, Hiyama E, Murakami Y, Ooge H, Uemura K, Tsumura H, Yokoyama T, Takeuchi H, Tanakaya K, Yasunami Y, Ryu S. Jpn J Antibiot; 2010 Apr; 63(2):105-70. PubMed ID: 20919496 [Abstract] [Full Text] [Related]
10. [In-vitro activity of panipenem against clinical isolates in 2006]. Yoshida S, Koga T, Kakuta M, Kobayashi I, Matsuzaki K, Urabe E, Omika K, Hasegawa M, Sato Y. Jpn J Antibiot; 2008 Feb; 61(1):1-17. PubMed ID: 18536215 [Abstract] [Full Text] [Related]
11. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Tanimoto H, Nakata K, Nakamori Y, Nakatani T, Kusano N. Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305 [Abstract] [Full Text] [Related]
12. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N. Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430 [Abstract] [Full Text] [Related]
13. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kawaguchi H, Shimizu Y, Matsumiya H, Saito A, Terai T, Inoue H, Nakadate T, Ito C, Yosida T, Tanno Y, Ohno I, Nishioka K, Arakawa M, Igarashi K, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Touyama M. Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366 [Abstract] [Full Text] [Related]
14. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria]. Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T. Jpn J Antibiot; 2002 Feb; 55(1):1-21. PubMed ID: 11977919 [Abstract] [Full Text] [Related]
15. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)]. Shimada K, Oguri T, Igari J, Ikemoto H, Mori T, Kitamura N, Nakano K, Suzuki Y, Yokouchi H, Karasawa Y, Terai T, Yamamoto M, Nakata K, Nakatani T, Inoue H, Nakadate T, Inagawa H, Suwabe A, Obata R, Kudo K, Kobayashi N, Ohno I, Okada S, Hayashi K, Kinoshita T, Konosaki H, Arakawa M, Gejyo F, Kobayashi H, Goto H, Igarashi K, Kawai S, Okada M, Ito A, Sumitomo M, Aoki N, Matsushima T, Niki Y, Suga M, Hirakata Y, Aoki S, Matsuda J, Tosaka M, Nasu M, Nagai H, Kohno S, Tomono K, Miyazaki Y, Hiramatsu K, Nakano T. Jpn J Antibiot; 2003 Oct; 56(5):365-95. PubMed ID: 14692377 [Abstract] [Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution]. Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Takanashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Kosakai N, Yamaguchi K, Matsumoto T, Kashitani F, Tanaka M. Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353 [Abstract] [Full Text] [Related]
17. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Matsuda M, Tanimoto H, Nakata K, Nakamori Y, Kusano N. Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860 [Abstract] [Full Text] [Related]
19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]. Ikemoto H, Ito C, Yoshida T, Watanabe K, Mori T, Ohno I, Okada S, Igari J, Arakawa M, Igarashi K, Oguri T, Okada M, Ozaki K, Terai T, Aoki N, Inoue H, Nakadate T, Kitamura N, Sekine O, Suzuki Y, Ando M, Suga M, Sato K, Nakata K, Kusano N. Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048 [Abstract] [Full Text] [Related]